There are several strategies that can be utilized to improve transfection efficiency while reducing the cytotoxicity of polyethyleneimine (PEI) as a promising non-viral gene delivery vector. In this study, we evaluated the potential use of lysinehistidine (KH) peptides in modifying the PEI 10 kDa structure and enhancing its efficiency while maintaining low toxicity of PEI. PEI 10 kDa was modified with 6-bromohexanoic acid (alkyl) to increase its lipophilicity. Then, ethylenediamine (EDA) was attached to the carboxylic groups of PEI-hexanoate to restore the primary amines of PEI. Subsequently, six different KH short peptides were conjugated to PEIs and evaluated for the effect of the KH sequence on vector transfection efficiency and cytotoxicity. The transfection efficiency of PEI-peptides complexed with a luciferase reporter gene (pRLCMV) in Neuro-2A murine neuroblastoma cells showed that the PEI conjugated to KHHHKKHHHK peptide had a significantly higher rate of gene transfection efficiency in comparison with other KH peptides. This peptide was conjugated to PEI-alkyl and PEI-alkyl-EDA and significant improvement in efficiency with minimal cytotoxicity was observed. The results obtained suggest that the sequence and content of KH peptides will have a significant impact on the transfection efficiency of modified PEI 10 kDa.
Introduction
The success of gene therapy is largely dependent on the development of safe and efficient gene delivery systems including viral and non-viral vectors. Non-viral vectors, such as cationic lipids, polymers, dendrimers and peptides, have recently attracted a great deal of attention because of their ease in preparation, flexibility in the size of the transgene and biocompatibility. [1] [2] [3] [4] Polyethyleneimine (PEI) is a polymeric non-viral vector that has shown promise to effectively condense nucleic acids into nanosize particles, facilitate their escape from endosomal compartments and mediate gene expression in a variety of mammalian cells. [5] [6] [7] The endosomolytic activity of PEI is proportional to its molecular weight and, as it increases, the ability to lyse endosomes increases. 8 For example, it has been shown that PEI 25 kDa can efficiently lyse endosomes and facilitate endosomal escape of vector/ pDNA complexes. 9 However, in low-molecular-weight PEIs (for example, 10 kDa), the endosomolytic effect is not strong enough to release all PEI/DNA complexes. 8, 10 Despite this inefficiency, PEI 10 kDa is a much safer polymer in comparison with PEI 25 kDa because of its significantly lower cell toxicity. 11 Abdallah et al. have shown the following order of cell toxicity with highmolecular-weight PEIs: PEI 25 kDa4PEI 50 kDa4PEI 800 kDa. 12 There are several strategies that can be utilized to improve transfection efficiency while reducing the cytotoxicity of PEI polyplexes. In one approach, peptides of short sequence such as KALA, RGD, TAT and so on have been conjugated to the PEI core in order to enhance its targetability, endosomolytic activity or cell penetration. [13] [14] [15] [16] Although PEI 10 kDa suffers from low transfection efficiency, its low toxicity makes it an attractive polymer for modification in order to overcome the shortcomings. Our group has recently reported the structure of a series of alkyl-oligoamine derivatives of PEI 10 kDa (that is, PEI-alkyl and PEI-alkyl-EDA) with enhanced efficiency due to increase in lipophilicity while maintaining low toxicity. 17, 18 These derivatives of PEI 10 kDa have transfection efficiency comparable to that of PEI 25 kDa, but with significantly lower cell toxicity.
Here, we evaluated the potential use of lysine-histidine (KH) peptides in modifying the PEI 10 kDa structure and enhancing its efficiency while maintaining low toxicity. To achieve this objective, branched PEI 10 kDa was modified with several short KH peptides with different sequences to enhance the endosomolytic activity of PEI without compromising its DNA condensing ability. We first hypothesized that the sequence and content of KH peptides will have a significant impact on the transfection efficiency of PEI 10 kDa. This hypothesis was formulated on the basis of previous studies by Hatefi et al., 19 and intended to help us identify the most efficient KH peptide sequence(s). On the basis of the results obtained from this study and our previous findings, 17 we formulated our second hypothesis. It was hypothesized that by modification of the structure of alkyl-modified PEI 10 kDa with KH peptides, the transfection efficiency can be increased while maintaining low toxicity.
Materials and methods

Materials
Branched PEI with an average molecular weight of 10 kDa was obtained from Polyscience, Inc (Warrington, PA). 6-bromohexanoic acid, ethylenediamine (EDA), N-hydroxybenzotriazole, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and N-(2-hydroxythyl) piperazine-N 0 -(2-ethanesulfonic acid) (HEPES) were purchased from Sigma-Aldrich (Munich, Germany). N-Succinimidyl 3-(2-pyridyldithio) propionate (SPDP) was purchased from Fluka (Buchs, Switzerland). Dulbecco's modified Eagle's medium and fetal bovine serum were supplied by GIBCO (Gaithersburg, MD). Ethidium bromide (EtBr) was purchased from Cinnagen (Tehran, Iran). KH-based peptides were obtained from CASLO Laboratories (Technical University of Denmark, Lyngby, Denmark). After synthesis, peptides were purified by high-pressure liquid chromatography (HPLC) (purity 495%) and sequences were confirmed by mass spectrometry.
Preparation of plasmid DNA Plasmid DNA encoding Renilla luciferase (pRL-CMV) (Promega, Madison, WI) was transformed into E. coli bacterial strain DH5a and extracted from culture pellets using a Qiagen endotoxin-free mega plasmid kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions.
Synthesis of 3-(2-pyridyldithiol) propionate-modified PEI PEI 10 kDa was treated with SPDP (cross-linking reagent) in HEPES buffer solution (2 ml, 20 mM, pH 8.0 containing 0.350 M NaCl) to prepare thiol-functionalized PEI for peptide conjugation. After stirring for 2 h at room temperature, the product was purified by dialysis against HEPES buffer (20 mM, pH 7.4 containing 0.25 mM NaCl) using an ultrafiltration cell equipped with a 5 kDa molecular weight cutoff membrane (Amicon, Beverly, MA). The reaction yield was determined by the formation of 2-thiopyridone detected at 343 nm after reduction of an aliquot of each product with excess dithiothreitol. The primary amine content of the products was determined by trinitrobenzenesulfonic acid (TNBS) assay at 405 nm as described previously. 20 Synthesis of peptide-conjugated PEI The activated PEI 10 kDa from the previous step was mixed separately with the KH peptides shown in Table 1 and kept under argon. The degree of grafting was adjusted to 10%, as calculated according to the primary amine contents, with 2.2 M excess. After 4 h incubation at room temperature, the released thiopyridone was measured at 343 nm to determine the extent of peptide conjugation. Unreacted peptides were removed by dialysis against HEPES buffer solution (20 mM, pH 7.4 containing 50 mM NaCl) using an ultrafiltration cell equipped with a 10 kDa molecular weight cutoff membrane (Amicon). The amine content of each product was determined by TNBS assay at 405 nm.
Reverse-phase high-pressure liquid chromatography (RP-HPLC) The final products were further analyzed by HPLC on a C18 reverse-phase column (5-mm, 250 Â 4.6 mm, perfectsil target, ods-3). After injection, gradient elution was performed at a flow rate of 1 ml min À1 with the mobile phases of 0.1%TFA in acetonitrile (solution A) and 0.1% TFA in H2O (solution B). The peptide elution was detected at 220 nm. To examine the conjugation of peptides to PEI-PDP, excess 2-mercaptoethanol-treated products were also injected into the HPLC column.
Preparation of PEI-hexanoate PEI-hexanoate was synthesized according to the previously reported method with minor modifications. 17 In brief, PEI 10 kDa (0.5 g) was dissolved in 5 ml dimethylformamide. 6-Bromohexanoic acid (0.88 g, 1.5 mol excess) was dissolved in dimethylformamide and added dropwise to the vigorously stirred PEI solution. After 24 h incubation at room temperature, the final product was dialyzed using dialysis Spectra/Por membrane with 8000-Da molecular weight cutoff (Spectrum Laboratories, Houston, TX) once against 0.25 M NaCl, then twice against water. This was to remove unreacted alkylating agents. The final purified product was lyophilized for further use. The degree of grafting was measured by TNBS assay at 405 nm.
Oligoamine coupling to PEI-hexanoate For oligoamine coupling, PEI-hexanoate was dissolved in distilled water and added to an aqueous solution containing The peptides were conjugated to the PEI 10 kDa and its derivatives.
EDA (as oligoamine) and N-hydroxybenzotriazole (coupling reagent). Then, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride dissolved in water was added to the previous solution. After 24 h incubation at room temperature, the final product was dialyzed against distilled water using dialysis membrane (10 000-Da cutoff, Spectra/Por membrane) to remove unreacted materials. The final product was lyophilized and the amount of primary amines of modified PEI was determined by TNBS assay.
Conjugation of KH peptides to PEI-hexanoate and PEI-hexanoate-EDA derivatives KH peptides were conjugated to PEI-hexanoate and PEI-hexanoate-EDA by disulfide bond formation using SPDP, as described in Materials and methods section. In all, 10% of the primary amines of PEI in these derivatives were coupled to KH peptides.
EtBr exclusion assay PEI derivatives were prepared in HEPES-buffered glucose buffer (1 ml, 20 mM, pH 7.4 containing 5% glucose) and added at different weight polymer/weight plasmid ratios to a solution containing pRL-CMV (5 mg ml -1 ) and EtBr (400 ng ml À1 ). Fluorescence intensity was measured at 510 nm excitation and 590 nm emission wavelengths using a Jasco FP-6200 spectrofluorimeter (Tokyo, Japan). The fluorescence intensity of DNA with EtBr corresponds to 0% condensation, whereas the fluorescence intensity of EtBr without plasmid corresponds to 100% condensation. Results are reported as mean±s.d., n ¼ 3.
Particle size and zeta potential measurements Various amounts of PEI or modified PEIs were added to a salt-free HEPES buffer (20 mM, 5% glucose, pH 7.4) and mixed with a fixed amount of pRL-CMV (5 mg) in equal volume of the same buffer. The mixture was incubated for 30 min at room temperature. The particle size and zeta potential were measured using Dynamic Light Scattering and Laser Doppler Velocimetry, respectively, by a Malvern NanoZS instrument and DTS software (Malvern Instruments, UK). Three independent samples (n ¼ 3) were prepared and the results are reported as mean ± s.e.m. Each mean represents the average value of 30 measurements from each independent sample.
Cell transfection with pRL-CMV For cell transfection, Neuro-2A murine neuroblastoma cells (ATCC, CCL-131) were seeded at a density of 1 Â 10 4 cells per well in 96-well plates and incubated in Dulbecco's modified Eagle's medium (1 gl À1 glucose) supplemented with 10% fetal bovine serum for 24 h. Polymer/pDNA (pRL-CMV) complexes at different weight/weight ratios ranging from 2:1, 4:1 and 6:1 were prepared in a final volume of 100 ml HEPES-buffered glucose. A volume of 10 ml of complexes (equivalent of 200 ng pRL-CMV) was added to each well. After 4 h, the medium was removed and replaced with fresh complete medium. The cells were further incubated for 24 h at 37 1C and the luciferase activity in cell lysates was measured using a promega luciferase assay kit on Luminometer (Brthlod Detection System, Pforzheim, Germany). The results are reported as mean ± s.d., n ¼ 3.
Cytotoxicity assay
Neuro-2A cells were seeded in 96-well plates at an initial density of 1 Â 10 4 cells per well and incubated for 24 h. Cells were then treated with the same amount of polyplex used for transfection experiment. After 3 h, the medium was replaced with fresh complete medium. After 24 h, 10-ml sterile filtered 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide stock solution in phosphatebuffered saline (5 mg ml À1 ) was added to each well and the absorbance was read at 575/630 nm. The cell viability (%) relative to control wells containing cell culture medium without polymer was calculated by
Erythrocyte leakage assay Human erythrocytes were isolated from fresh citratetreated blood and washed with phosphate-buffered saline four times (by centrifuging at 800 Â g for 10 min at 4 1C). The erythrocyte pellet was diluted 10-fold in 150 mM NaCl. PEI-based polymers were serially diluted in 75 ml HEPES-buffered glucose buffer containing 150 mM NaCl using a V-bottom 96-well plate. The concentration of polymers varied from 0.25 to 16 mM. For 100% lysis, 1% Triton-X 100 was added to the erythrocyte suspension and used as positive control. The plates were incubated at 37 1C for 30 min under constant shaking. After centrifugation at 300 g for 10 min, 70 ml supernatant was analyzed for hemoglobin release at 405 nm using a microplate reader. Experiments were performed in triplicate.
Results and discussion
Peptide conjugation to PEI
In an attempt to develop a safe and efficient PEI-based gene delivery system, a series of KH peptides with different histidine and lysine content and sequence were synthesized and conjugated to the branched PEI 10 kDa. The role of lysine residues is to bind to DNA and neutralize its negative charges, whereas histidine residues are expected to facilitate endosomolysis and escape of the cargo into the cytosol. The application of such peptides in gene delivery to various mammalian cells has been demonstrated by several groups who are cited in reference. 21, 22 In a recent report by Hatefi et al., 19 it has been shown that, besides peptide content, the sequence could also significantly impact gene transfection efficiency. Therefore, six peptides with different histidine and lysine contents and sequences (Table 1) were synthesized, conjugated to PEI 10 kDa via a disulfide bridge and evaluated for their gene transfer efficiency and toxicity. Figure 1 shows the synthetic chemical methods used to conjugate the KH peptides to PEI 10 kDa, resulting in the production of PEI-PEP1, PEI-PEP2, PEI-PEP3, PEI-PEP4, PEI-PEP5 and PEI-PEP6. The results of the reaction between PEI and SPDP indicated that approximately 10% of the PEI amines were modified by SPDP and were activated. After addition of KH peptides, RP-HPLC demonstrated that B90% of the activated PEI was bound to KH peptides via disulfide bridges.
Characterization of PEI-peptide/DNA complexes
In the next step, all KH-modified PEIs were examined for their ability to condense pDNA using EtBr exclusion assay. Free EtBr shows only weak fluorescence, but its fluorescence is strongly enhanced when it intercalates into DNA. Condensation of pDNA by polymers decreases fluorescence intensity by inhibiting the intercalation process. The results of EtBr exclusion assay indicated that all polymers can effectively condense pDNA at c/p ratio 1 (Figure 2 ). All KH-modified PEIs reduced the fluorescence intensity of EtBr by more than 80%. In addition, we did not observe any significant difference between binding affinity of PEI 10 kDa and its derivatives. This could be because of the low degree of substitution of PEI by KH peptides (that is, B10%).
The ability of KH-modified PEIs to condense pDNA into nanosize particles was studied by a zetasizer. Particle size measurement results displayed a typical particle size between 40 and 60 nm (Figure 3 ). In addition, it was found that these nanoparticles had the net positive surface charge varying from 18 to 30 mV. No significant difference between the surface charge of the particles formed with various KH-modified PEIs was observed. These results indicate that the surface modification of PEI with various KH peptides did not compromise the ability of PEI 10 kDa to form nanosize particles suitable for cellular uptake.
Cell transfection efficiency and cytotoxicity of peptide-conjugated PEI The ability of polymer/pDNA nanosize particles to transfect mammalian cells was evaluated in Neuro-2A murine neuroblastoma cells. Cells were transfected with 200 ng of pRL-CMV in complex with PEI or KHmodified PEIs at various c/p ratios. As shown in Figure 4 , the highest rates of gene transfection efficiency were observed at c/p 4 and 6. This could be because of the fact that at c/p ratio 2, the pDNA is not fully condensed. At c/p 4, the transfection efficiencies of PEI-PEP1, PEI-PEP2, PEI-PEP3 and PEI-PEP6 were similar to that of unmodified PEI (P40.05, t-test), whereas there was a significant decrease in efficiency with PEI-PEP4 and PEI-PEP5. At c/p 6, only PEI-PEP1, PEI-PEP2 and PEI-PEP6 produced the same transfection efficiency as unmodified PEI. In addition, at c/p 4, PEI-PEP6 had a significantly higher rate of gene -transfection efficiency in comparison with the other KH peptides. Before drawing any Peptide-modified polyethyleneimine M Hashemi et al conclusion with regard to the most efficient construct, we examined the toxicity of these polymers, as cell toxicity could directly impact efficiency.
The cytotoxicity of unmodified and modified PEIs was evaluated in Neuro-2A cells using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The results demonstrated that at c/p ratios of 2 and 4, polymers were not toxic and were in the same range as unmodified PEI 10 kDa (P40.05, t-test) ( Figure 5 ). However, significant toxicity was observed with all polymers at c/p ratio of 6. These observations are similar to the previously reported data by our group and others. 17, 18 These results, in combination with the results of the transfection efficiency study, show that the optimum c/p ratio for cell transfection is 4. At this c/p ratio, at which all polymers are non-toxic, PEI-PEP6 has the highest rate of gene transfer efficiency. By considering its sequence and comparing with other peptides, it can be observed that not only did histidine content have a significant impact on efficiency but the distribution of lysine residues among histidines also had a role.
Synthesis and characterization of PEI-alkyl-peptide and PEI-alkyl-EDApeptide/DNA polymers On the basis of these findings, we used PEP1, PEP2 and PEP6 as the best candidates to examine our second hypothesis. We have previously demonstrated that modification of PEI 10 kDa with 6-bromohexanoic acid enhances transfection efficiency while maintaining low toxicity. 17 Therefore, we used PEI-alkyl as the base and modified its structure by conjugation with PEP1, PEP2 and PEP6 to generate PEI-alkyl-PEP1, PEI-alkyl-PEP2 and PEI-alkyl-PEP6. We also evaluated the transfection efficiency and toxicity of PEI-alkyl-EDA modified with PEP1, PEP2 and PEP6. The role of EDA is to restore the primary amine content of PEI after alkylation, which could impact transfection efficiency. The steps that are involved with the chemical conjugation of PEP1, PEP2 and PEP6 to PEI-alkyl and PEI-alkyl-EDA are shown in Figure 6 .
Once synthesized, the degrees of substitution of PEI conjugates were assayed by TNBS assay. Results showed that the degree of grafting was 8 and 8.5% for alkylation and oligoamine (EDA), respectively. The ability of modified PEIs (eight new constructs) to condense pDNA was evaluated using EtBr exclusion assay as discussed The results demonstrated that all new PEI derivatives were able to condense pDNA as efficiently as PEI 10 kDa (Supplementary Figure 1) . In the next step, we examined the ability of the alkylconjugated products in terms of their ability to condense pDNA into nansosize particles. The results of this study revealed that all constructs were able to condense pDNA into nanoparticles with sizes less than 80 nm. Similar to that which we have reported previously, 17 nanoparticles formed with PEI-alkyl had significantly lower zeta potential (13 ± 1.8 mV) in comparison with nanoparticles formed with unmodified PEI (23±1.2 mV) (Supplementary Figure 2 ). We did not observe any statistical difference between the sizes of the particles formed with PEI-Alkyl, PEI-Alkyl-EDA and PEI-Alkyl-PEP6.
Before measuring the transfection efficiency of the newly developed constructs, we evaluated their cell toxicity. The result of this study showed that none of the PEI derivatives had any significant toxicity at c/p ratios tested (Figure 7) . On the basis of our previously published data and the cell toxicity data shown in Figure 5 , these results were expected. Knowing that none of these polymers were toxic to cells, we measured their ability to transfect cells in order to identify the high-performing construct. As shown in Figure 8 , modification of PEI with alkyl and EDA led to significantly higher transfection efficiency (Po0.001) in comparison with PEI 10 kDa. Overall, the highest-performing constructs were PEI-alkyl-PEP6 and PEI-alkyl-EDA-PEP6. These two constructs appear to be the most suitable constructs for gene transfer as they can transfect cells at the same levels as PEI-alkyl or PEI-alkyl-EDA but at a lower c/p ratio (half the amount). This is considered as a significant improvement because PEI is inherently nonbiodegradable, and using less of it makes it safer for longterm gene therapy applications.
In the next step, we studied the potential lytic properties of the high-performing constructs (i.e., PEI-alkyl-PEP6 and PEI-alkyl-EDA-PEP6), which were identified from the previous steps. It has previously been shown that cationic peptides could potentially destabilize cell membranes and result in their lysis. 23 The results of the erythrocyte leakage assay revealed that these peptides did not have any significant lytic activity and are potentially safe ( Figure 9 ). This could perhaps be another reason behind the fact that we did not observe any significant polymer-related cell toxicity in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.
In conclusion, the results showed that histidine content and the distribution of lysine residues among histidines could have a significant impact on the transfection efficiency of modified PEI 10 kDa. The peptide with the sequence of KHHHKKHHHK conjugated to the modified PEI had a significantly higher rate of gene transfection efficiency in comparison with other KH peptides. The possible reason for the improved transfection observed for this sequence is the suitable pKa of imidazole groups of histidines in this peptide, which can enhance the release of DNA from the acidic environment of endosomes or enhance the interaction with endosomal membranes for effective disruption. The above-mentioned results are encouraging and justify further evaluation of the efficacy and toxicity of the high-performing constructs in animal models to determine its utility for future clinical applications. Peptide-modified polyethyleneimine M Hashemi et al
